Genomic losses at 5q13.2 and 8p23.1 in dysplastic hepatocytes are common events in hepatitis B virus-related hepatocellular carcinoma

Zhao,Zhang; Chen,Guang‑Yong; Long,Jiang; Li,Hai; Huang,Jian

doi:10.3892/ol.2015.3140

Genomic losses at 5q13.2 and 8p23.1 in dysplastic hepatocytes are common events in hepatitis B virus-related hepatocellular carcinoma

Authors:
- Zhang Zhao
- Guang‑Yong Chen
- Jiang Long
- Hai Li
- Jian Huang
View Affiliations

Affiliations: Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, P.R. China, Department of Pathology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, P.R. China, Minimally Invasive Hepatobiliary Cancer Center, Beijing You‑An Hospital, Capital Medical University, Beijing 100069, P.R. China, Department of Hepatopancreatobiliary and Splenic Medicine, Affiliated Hospital of Medical College of Chinese People's Armed Police Force, Tianjin 300192, P.R. China
Published online on: April 23, 2015 https://doi.org/10.3892/ol.2015.3140
Pages: 2839-2846

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Chromosomal loci with genomic imbalances are frequently identified in hepatocellular carcinoma (HCC). Greater than two‑thirds of hepatitis B virus (HBV)‑related HCCs originate from liver cirrhosis following a duration of up to two decades. However, it is unclear whether these genomic imbalances occur and accumulate in dysplastic hepatocytes of the cirrhotic liver during the progression from regenerated nodules to preneoplastic lesions, including dysplastic nodules (DN). In the present study, high‑grade DNs (HGDNs) of HBV‑related liver cirrhosis were screened to identify loci with genomic imbalances, and the frequency of the identified loci in a group of HCCs was analyzed in order to determine whether there may be a genetic link between liver cirrhosis and HCC. Genomic DNA was extracted from six HGDNs of two cases of HBV‑related liver cirrhosis and subjected to array comparative genomic hybridization (CGH) analysis with a NimbleGen 720K microarray. Loci with the most frequently observed genomic imbalances in DNs were further analyzed in 83 cases of HCC by differential polymerase chain reaction (PCR) and quantitative PCR. The array CGH analysis revealed that the majority of genomic imbalances in the HGDNs were genomic losses of small segments, with loss of heterozygosity (LOH) at 5q13.2 and 8p23.1 identified most frequently. Of the 83 HCC cases, 30 (36.1%) cases were identified with LOH at 5q13.2, where known tumor‑associated genes are located, including general transcription factor IIH subunit 2 (GTF2H2), baculoviral IAP repeat‑containing protein 1 (BIRC1) and occludin (OCLN). LOH frequency at 8p23.1 in HCC was 61.29% (D8S1130) and 68.4% (D8S503) respectively, similar to the results obtained in previous studies. In conclusion, the results of the present study provided evidence that genomic losses at 5q13.2 and 8p23.1 identified in dysplastic hepatocytes of the cirrhotic liver are common events in HCC. HCC‑associated chromosomal abnormalities may occur and accumulate in preneoplastic lesions of liver cirrhosis.

View Figures

View References

1	Theise ND, Chen CJ and Kew MC: Liver cancerWorld Cancer Report 2014. Stewart B and Wild C: International Agency for Research on Cancer; Lyon: pp. 577–593. 2014
2	Hsu YS, Chien RN, Yeh CT, et al: Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology. 35:1522–1527. 2002. View Article : Google Scholar : PubMed/NCBI
3	Kim TM, Yim SH, Shin SH, et al: Clinical implication of recurrent copy number alterations in hepatocellular carcinoma and putative oncogenes in recurrent gains on 1q. Int J Cancer. 123:2808–2815. 2008. View Article : Google Scholar : PubMed/NCBI
4	Patil MA, Gütgemann I, Zhang J, et al: Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma. Carcinogenesis. 26:2050–2057. 2005. View Article : Google Scholar : PubMed/NCBI
5	Midorikawa Y, Tang W and Sugiyama Y: High-resolution mapping of copy number aberrations and identification of target genes in hepatocellular carcinoma. Biosci Trends. 1:26–32. 2007.PubMed/NCBI
6	Guo X, Yanna, Ma X, et al: A meta-analysis of array-CGH studies implicates antiviral immunity pathways in the development of hepatocellular carcinoma. PLoS One. 6:e284042011. View Article : Google Scholar : PubMed/NCBI
7	Han ZG: Recent progress in genomic research of liver cancer. Sci China C Life Sci. 52:24–30. 2009. View Article : Google Scholar : PubMed/NCBI
8	International Consensus Group for Hepatocellular Neoplasia: Pathologic diagnosis of early hepatocellular carcinoma: A report of the international consensus group for hepatocellular neoplasia. Hepatology. 49:658–664. 2009. View Article : Google Scholar : PubMed/NCBI
9	International Working Party: Terminology of nodular hepatocellular lesions. Hepatology. 22:983–993. 1995. View Article : Google Scholar : PubMed/NCBI
10	Di Tommaso L, Sangiovanni A, Borzio M, et al: Advanced precancerous lesions in the liver. Best Pract Res Clin Gastroenterol. 27:269–284. 2013. View Article : Google Scholar : PubMed/NCBI
11	Sobin LH and Wittekind CH: TNM Classification of Malignant Tumours. 6th. Wiley; New York, NY: pp. 81–83. 2002
12	Theise ND, Curado MP, Franceschi S, et al: Hepatocellular carcinomaWHO Classification of Tumors of the Digestive System. Bosman FT, Carneiro F, Hruban RH and Theise ND: International Agency for Research on Cancer; Lyon: pp. 205–216. 2010
13	Huang J, Grotzer MA, Watanabe T, et al: Mutations in the Nijmegen breakage syndrome gene in medulloblastomas. Clin Cancer Res. 14:4053–4058. 2008. View Article : Google Scholar : PubMed/NCBI
14	Huang J, Pang J, Watanabe T, Ng HK and Ohgaki H: Whole genome amplification for array comparative genomic hybridization using DNA extracted from formalin-fixed, paraffin-embedded histological sections. J Mol Diagn. 11:109–116. 2009. View Article : Google Scholar : PubMed/NCBI
15	Sun FY, Wan DF, Qing WX, et al: Determination of gene deletion in tumor tissue by semi-quantitative polymerase chain reaction. Tumor. 20:135–137. 2000.(In Chinese).
16	Tomlinson IP, Lambros MB and Roylance RR: Loss of heterozygosity analysis: Practically and conceptually flawed? Genes Chromosomes Cancer. 34:349–353. 2002. View Article : Google Scholar : PubMed/NCBI
17	Zhou HL, Gong L, Zhang W, Du YX, Zhang JY and Feng YM: Loss of heterozygosity on chromosomes 8 and 16 in primary hepatocellular carcinoma. Xian Dai Zhong Liu Yi Xue. 20:1134–1138. 2012.(In Chinese).
18	Lau SH and Guan XY: Cytogenetic and molecular genetic alterations in hepatocellular carcinoma. Acta Pharmacol Sin. 26:659–665. 2005. View Article : Google Scholar : PubMed/NCBI
19	Niketeghad F, Decker HJ, Caselmann WH, et al: Frequent genomic imbalances suggest commonly altered tumour genes in human hepatocarcinogenesis. Br J Cancer. 85:697–704. 2001. View Article : Google Scholar : PubMed/NCBI
20	Rashid A, Wang JS, Qian GS, Lu BX, Hamilton SR and Groopman JD: Genetic alterations in hepatocellular carcinomas: association between loss of chromosome 4q and p53 gene mutations. Br J Cancer. 80:59–66. 1999. View Article : Google Scholar : PubMed/NCBI
21	Zondervan PE, Wink J, Alers JC, et al: Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias. J Pathol. 192:207–215. 2000. View Article : Google Scholar : PubMed/NCBI
22	Laurent-Puig P, Legoix P, Bluteau O, et al: Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis. Gastroenterology. 120:1763–1773. 2001. View Article : Google Scholar : PubMed/NCBI
23	Gong L, Li YH, Su Q, Chu X and Zhang W: Clonality of nodular lesions in liver cirrhosis and chromosomal abnormalities in monoclonal nodules of altered hepatocytes. Histopathology. 56:589–599. 2010. View Article : Google Scholar : PubMed/NCBI
24	Kakar S, Chen X, Ho C, et al: Chromosomal abnormalities determined by comparative genomic hybridization are helpful in the diagnosis of atypical hepatocellular neoplasms. Histopathology. 55:197–205. 2009. View Article : Google Scholar : PubMed/NCBI
25	Zhang F, Zhou C, Ling Y, et al: Allelic analysis on chromosome 5 in sporadic colorectal cancer patients. Zhonghua Zhong Liu Za Zhi. 24:458–460. 2002.(In Chinese). PubMed/NCBI
26	Ding SF, Habib NA, Dooley J, et al: Loss of constitutional heterozygosity on chromosome 5q in hepatocellular carcinoma without cirrhosis. Br J Cancer. 64:1083–1087. 1991. View Article : Google Scholar : PubMed/NCBI
27	Johannsdottir HK, Jonsson G, Johannesdottir G, et al: Chromosome 5 imbalance mapping in breast tumors from BRCA1 and BRCA2 mutation carriers and sporadic breast tumors. Int J Cancer. 119:1052–1060. 2006. View Article : Google Scholar : PubMed/NCBI
28	Huang XS, Xiao L, Li X, et al: Two neighboring microdeletions of 5q13.2 in a child with oculo-auriculo-vertebral spectrum. Eur J Med Genet. 53:153–158. 2010. View Article : Google Scholar : PubMed/NCBI
29	Chen CP, Lin CJ, Chen CY, et al: Maternal transmission of interstitial microdeletion in 5q13.2 detected during prenatal diagnosis of coarctation of the aorta. Taiwan J Obstet Gynecol. 52:303–305. 2013. View Article : Google Scholar : PubMed/NCBI
30	Markaverich BM, Shoulars K and Rodriquez MA: Luteolin regulation of estrogen signaling and cell cycle pathway genes in MCF-7 human breast cancer cells. Int J Biomed Sci. 7:101–111. 2011.PubMed/NCBI
31	Du D, Xu F, Yu L, Zhang C, Lu X, Yuan H, et al: The tight junction protein, occludin, regulates the directional migration of epithelial cells. Dev Cell. 18:52–63. 2010. View Article : Google Scholar : PubMed/NCBI
32	Kahng YS, Lee YS, Kim BK, Park WS, Lee JY and Kang CS: Loss of heterozygosity of chromosome 8p and 11p in the dysplastic nodule and hepatocellular carcinoma. J Gastroenterol Hepatol. 18:430–436. 2003. View Article : Google Scholar : PubMed/NCBI
33	Chan KL, Lee JM, Guan XY, Fan ST and Ng IO: High-density allelotyping of chromosome 8p in hepatocellular carcinoma and clinicopathologic correlation. Cancer. 94:3179–3185. 2002. View Article : Google Scholar : PubMed/NCBI
34	Pineau P, Nagai H, Prigent S, et al: Identification of three distinct regions of allelic deletions on the short arm of chromosome 8 in hepatocellular carcinoma. Oncogene. 18:3127–3134. 1999. View Article : Google Scholar : PubMed/NCBI
35	Lu T, Hano H, Meng C, et al: Frequent loss of heterozygosity in two distinct regions, 8p23.1 and 8p22, in hepatocellular carcinoma. World J Gastroenterol. 13:1090–1097. 2007. View Article : Google Scholar : PubMed/NCBI